Prenatal exposure to respiratory syncytial virus alters postnatal immunity and airway smooth muscle contractility during early-life reinfections

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Brown, Paul M ^a   Harford, Terri J ^a   Agrawal, Vandana ^a   Yen Lieberman, Belinda ^a   Rezaee, Fariba ^a   Piedimonte, Giovanni ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PRENATAL EXPOSURE; RAT; RECURRENT INFECTION; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; SMOOTH MUSCLE CONTRACTILITY; ANIMAL; BRONCHUS HYPERREACTIVITY; DISEASE MODEL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; IMMUNOPHENOTYPING; MATERNAL EXPOSURE; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; SMOOTH MUSCLE; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ANIMALS; BIOMARKERS; BRONCHIAL HYPERREACTIVITY; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOPHENOTYPING; MATERNAL EXPOSURE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOTYPE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTE SUBSETS;

EID: 85012008736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168786     Document Type: Article

References (49)

1. Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol. 2011; 46:324-47. doi: 10.1002/ppul.21377 PMID: 21438168
2. Byington CL, Wilkes J, Korgenski K, Sheng X. Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Pediatrics. 2015; 135:e24-31. doi: 10.1542/peds.2014-2151 PMID: 25489019
3. Sims DG, Downham MA, Gardner PS, Webb JK, Weightman D. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J. 1978; 1:11-4. PMID: 620129
4. Mok JY, Simpson H. Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child. 1984; 59:306-9. PMID: 6721555
5. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999; 354:541-5. doi: 10.1016/S0140-6736(98)10321-5 PMID: 10470697
6. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000; 161:1501-7. doi: 10.1164/ajrccm.161.5.9906076 PMID: 10806145
7. Noble V, Murray M, Webb MS, Alexander J, Swarbrick AS, Milner AD. Respiratory status and allergy nine to 10 years after acute bronchiolitis. Arch Dis Child. 1997; 76:315-9. PMID: 9166022
8. Openshaw PJM, Dean GS, Culley FJ. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J. 2003; 22:S58-S65. doi: 10.1097/01.inf.0000053887.26571.eb PMID: 12671454
9. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969; 89:422-34. PMID: 4305198
10. Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969; 89:449-63. PMID: 4305200
11. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis. Pediatr Rev. 2014; 35:519-30. doi: 10.1542/pir.35-12-519 PMID: 25452661
12. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 1989; 337:362-4. doi: 10.1038/337362a0 PMID: 2911387
13. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A. 1996; 93:10955-60. PMID: 8855290
14. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, Aloe L, et al. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2005; 172:233-7. doi: 10.1164/rccm.200412-1693OC PMID: 15879412
15. Piedimonte G, Walton C, Samsell L. Vertical transmission of respiratory syncytial virus modulates preand postnatal innervation and reactivity of rat airways. PLoS One. 2013; 8:e61309. doi: 10.1371/journal.pone.0061309 PMID: 23637810
16. Manti S, Brown P, Perez MK, Piedimonte G. The role of neurotrophins in inflammation and allergy. In: Litwack G, editor. Neurotrophins. Vitamins and Hormones, volume 104. Cambridge, Massachusetts: Academic Press/Elsevier; 2016.
17. Baker CA, Swainson L, Lin DL, Wong S, Hartigan-O'Connor DJ, Lifson JD, et al. Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge. Sci Transl Med. 2015; 7:300ra125. doi: 10.1126/scitranslmed.aac5547 PMID: 26268312
18. Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol. 1998; 54:320-7. PMID: 9557299
19. Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology. 2000; 48:237-47. PMID: 10960663
20. Yui I, Hoshi A, Shigeta Y, Takami T, Nakayama T. Detection of human respiratory syncytial virus sequences in peripheral blood mononuclear cells. J Med Virol. 2003; 70:481-9. doi: 10.1002/jmv.10421 PMID: 12767015
21. Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol. 2005; 32:307-10. doi: 10.1016/j.pediatrneurol.2005.01.010 PMID: 15866430
22. Li XQ, Fu ZF, Alvarez R, Henderson C, Tripp RA. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J Virol. 2006; 80:537-40. doi: 10.1128/JVI.80.1.537-540.2006 PMID: 16352577
23. Torres JP, Gomez AM, Khokhar S, Bhoj VG, Tagliabue C, Chang ML, et al. Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice. Respir Res. 2010; 11:125. doi: 10.1186/1465-9921-11-125 PMID: 20843364
24. Menchise A. Myocarditis in the setting of RSV bronchiolitis. Fetal Pediatr Pathol. 2011; 30:64-8. doi: 10.3109/15513815.2010.505632 PMID: 21204669
25. Kirin BK, Topic RZ, Dodig S. Hepatitis during respiratory syncytial virus infection-a case report. Biochem Med. 2013; 23:112-6.
26. Kim L. Respiratory Syncytial Virus (RSV) and RSV Vaccines 2016. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2016-06/rsv-02-kim.pdf.
27. Wu J, Xie A, Chen W. Cytokine regulation of immune tolerance. Burns Trauma. 2014; 2:11-7. PMID: 27574641
28. Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2015; 6:10224. doi: 10.1038/ncomms10224 PMID: 26687547
29. Darwich L, Coma G, Pena R, Bellido R, Blanco EJ, Este JA, et al. Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology. 2009; 126:386-93. doi: 10.1111/j.1365-2567.2008.02905.x PMID: 18759749
30. Gonzalez PA, Carreno LJ, Bueno SM, Riedel CA, Kalergis AM. Understanding respiratory syncytial virus infection to improve treatment and immunity. Curr Mol Med. 2013; 13:1122-39. PMID: 23157678
31. Gonzalez PA, Bueno SM, Riedel CA, Kalergis AM. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem. 2009; 16:4609-25. PMID: 19903147
32. Munir S, Hillyer P, Le Nouen C, Buchholz UJ, Rabin RL, Collins PL, et al. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 2011; 7:e1001336. doi: 10.1371/journal.ppat.1001336 PMID: 21533073
33. Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007; 195:1126-36. doi: 10.1086/512615 PMID: 17357048
34. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999; 282:1440-6. PMID: 10535434
35. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986; 140:543-6. PMID: 3706232
36. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991; 163:693-8. PMID: 2010624
37. Habibi MS, Jozwik A, Makris S, Dunning J, Paras A, DeVincenzo JP, et al. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am J Respir Crit Care Med. 2015; 191:1040-9. doi: 10.1164/rccm.201412-2256OC PMID: 25730467
38. Henderson FW, Collier AM, Clyde WA Jr., Denny FW. Respiratory syncytial virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979; 300:530-4. doi: 10.1056/NEJM197903083001004 PMID: 763253
39. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001; 33:792-6. doi: 10.1086/322657 PMID: 11512084
40. Mejias A, Dimo B, Suarez NM, Garcia C, Suarez-Arrabal MC, Jartti T, et al. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 2013; 10:e1001549. doi: 10.1371/journal.pmed.1001549 PMID: 24265599
41. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, et al. Local interferongamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis. 2001; 184:355-8. doi: 10.1086/322035 PMID: 11443563
42. Mella C, Suarez-Arrabal MC, Lopez S, Stephens J, Fernandez S, Hall MW, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2013; 207:564-73. doi: 10.1093/infdis/jis721 PMID: 23204162
43. Murray M, Webb MS, O'Callaghan C, Swarbrick AS, Milner AD. Respiratory status and allergy after bronchiolitis. Arch Dis Child. 1992; 67:482-7. PMID: 1580676
44. Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol. 2002; 283:L494-502. doi: 10.1152/ajplung.00414.2001 PMID: 12114213
45. Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev. 2015; 16:232-40. doi: 10.1016/j.prrv.2015.05.005 PMID: 26074450
46. Piedimonte G, Hegele RG, Auais A. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats. Pediatr Res. 2004; 55:657-65. doi: 10.1203/01.PDR.0000112244.72924.26 PMID: 14711892
47. Sasser JM, Baylis C. The natriuretic and diuretic response to dopamine is maintained during rat pregnancy. Am J Physiol Renal Physiol. 2008; 294:F1342-4. doi: 10.1152/ajprenal.00067.2008 PMID: 18400873
48. Guerrero-Plata A, Casola A, Suarez G, Yu X, Spetch L, Peeples ME, et al. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am J Respir Cell Mol Biol. 2006; 34:320-9. doi: 10.1165/rcmb.2005-0287OC PMID: 16284360
49. Techaarpornkul S, Barretto N, Peeples ME. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol. 2001; 75:6825-34. doi: 10.1128/JVI.75.15.6825-6834.2001 PMID: 11435561